Description
A blend combining CJC-1295 and Ipamorelin for laboratory investigation of growth-hormone-related signaling and peptide interactions. For laboratory use only; not for human or veterinary use.
Product overview
This blend combines two compounds associated with growth-hormone signaling. CJC-1295 is a growth-hormone-releasing-hormone analogue; ipamorelin was investigated as a growth-hormone secretagogue in experimental pharmacology.
The CJC-1295 paper below studied a long-acting formulation. It does not validate a formulation described as without DAC, or this combined product. The references are component studies, not evidence that the blend has an established benefit, safety profile or administration schedule.
References
Read the original publications for methods, limitations and the preparation studied.
